knowledge -WSS

knowledge

author：focus 2025-09-14 08:29:28 - browse：843

Five people put coins in a box containing coins and cash on stage — coverage from STAT — Adobe

In the United States, health care costs are so out of control that medical crowdfunding has become commonplace. The idea is simple: turn your social network into a financial safety net to cover the cost of expensive treatments or long illnesses. Millions of Americans have started crowdfunding campaigns for medical bills, and tens of millions have donated to them, mostly through the undisputed sector leader, GoFundMe.

Nora Kenworthy, a nursing and health studies professor at the University of Washington, Bothell, has spent years studying the world of crowdfunding for health care — along with the way it ends up amplifying the inequities that already dictate who goes into medical debt.

In her new book, “Crowded Out: The True Costs of Crowdfunding Healthcare,” which will be released on Tuesday, she looks at what she calls the “toxicities” that drive medical crowdfunding campaigns. STAT spoke with Kenworthy about those issues, as well as the difficult moral decisions potential donors face when deciding whether to contribute. The following interview is condensed and edited for clarity.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Amylyx ALS drug failure raises questions and concerns

focus

WSS

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

IVF, abortion rights issues kick off Biden’s State of the Union

Sen. Paul opposes bill to ban Chinese biotechs

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

RSV shot was 90% effective at preventing hospitalizations in kids

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

At least 13 dead in Texas as scorching temps continue

HHS names first

Hepatitis C has a cure — but many Americans still lack access to it

Health and fitness trackers are measuring the wrong things

Wildfire smoke exposes gaps in outdoor worker protections

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Headspace, Meta partner to launch VR meditation app for Quest

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

hotspot

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Designating disabled people as health disparity population is crucial

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Just how do doctors, lawmakers, and the public define abortion?

Amylyx ALS drug fails large clinical trial

Change Healthcare cyberattack prompts Medicare loan program

hotspot

entertainment

focus

leisure time